Mottiwala Aziz bought TARS
March 15, 2026 · Form 4 insider transaction
Mottiwala Aziz bought 26,482 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,482
Price
N/A
Total value
N/A
InsiderMottiwala Aziz
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 15, 2026
Filing dateMarch 17, 2026
Shares owned after74,536
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").; Includes 497 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025.